Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments.
about
Identification of postoperative prognostic microRNA predictors in hepatocellular carcinomaImmunohistochemistry for Pathologists: Protocols, Pitfalls, and TipsOn the Use of Fractional Polynomial Models to Assess Preventive Aspect of Variables: An Example in Prevention of Mortality Following HIV InfectionBinary partitioning for continuous longitudinal data: categorizing a prognostic variable.Predicting long-term outcome after traumatic brain injury using repeated measurements of Glasgow Coma Scale and data mining methods.Predicting the occurrence of major adverse cardiac events within 30 days of a vascular surgery: an empirical comparison of the minimum p value method and ROC curve approach using individual patient data meta-analysis.Polychotomization of continuous variables in regression models based on the overall C index.PrognoScan: a new database for meta-analysis of the prognostic value of genes.Biostatistics: a toolkit for exploration, validation, and interpretation of clinical data.Determining the optimal number and location of cutoff points with application to data of cervical cancer.Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer.Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients.HURP expression-assisted risk scores identify prognosis distinguishable subgroups in early stage liver cancer.Semiparametric smoothing of discrete failure time data.Temporal clustering of hemorrhages from untreated cavernous malformations of the central nervous system.Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma.A novel method to handle the effect of uneven sampling effort in biodiversity databases.Use of generalised additive models to categorise continuous variables in clinical predictionOptimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma.Do diagnosis delays impact receipt of test results? Evidence from the HIV early infant diagnosis program in UgandaAltered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer.The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markersPrognostic Impact of Immune Microenvironment in Lung Squamous Cell Carcinoma: Tumor-Infiltrating CD10+ Neutrophil/CD20+ Lymphocyte Ratio as an Independent Prognostic FactorD-Dimer Can Serve as a Prognostic and Predictive Biomarker for Metastatic Gastric Cancer Treated by ChemotherapyImpact of academic affiliation on radical cystectomy outcomes in North America: A population-based study.Novel risk scores for survival and intracranial failure in patients treated with radiosurgery alone to melanoma brain metastases.Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimizationA Review of Cutoffs for Nutritional Biomarkers.On representing the prognostic value of continuous gene expression biomarkers with the restricted mean survival curve.Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma.A general approach to categorizing a continuous scale according to an ordinal outcome.Comprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes.A new simplified immediate prognostic risk score for patients with acute myocardial infarction.Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma.Predictive validity of a brief antiretroviral adherence index: retrospective cohort analysis under conditions of repetitive administration.Age Is the Only Predictor of Poor Bowel Preparation in the Hospitalized Patient.Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes.Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma.Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma.The type of patients who would benefit from anti-androgen withdrawal therapy: could it be performed safely for aggressive prostate cancer?
P2860
Q21134574-1D390A13-98EE-4234-BB88-7A8A9B8CE642Q28068456-8B1BEF42-3186-414D-BE09-2E510C8771B8Q28704413-EBA962AC-D158-4BA2-9372-342B5DFAD049Q30743103-AA63DB3A-40E0-4570-9967-ABC13A44AA14Q30886779-F6F28B49-8468-4FD9-BE81-FE4823288B27Q31073733-1B3706AE-1F19-42F5-8548-2F86C82BA7B0Q33266613-763725DB-E23B-402D-BF81-AF7990E0EA66Q33434943-67A0588C-E06E-48E4-8F3F-18FE5CDAE518Q33518386-B0431A39-6BC1-4F2B-BFD9-1C115DAAA7CCQ33610844-CED5300C-1B30-4401-9213-7DFB32549CF7Q33710746-0812A66E-D31D-458F-893F-7E5FDE20C3E7Q33883653-8E467EF3-D13F-4FCB-AC7A-B5AD6927D769Q34056283-CCD14A0B-91BF-4896-9523-FC5F89AB320EQ34101405-64659FC7-95C7-4AC0-90D7-4CC88E36DD72Q34300479-FE55B670-8186-4A6D-8CCF-0705755B8745Q34354554-8665C20B-6CCB-4087-91DE-D0F511AD2E14Q34551048-17E52935-011B-4839-AC39-B1B87C0784B6Q34784776-9C6E84E6-E3B5-412E-9A34-3F61111088FDQ34959939-C4A7EACD-2B71-42D4-AD1A-E51D616FD06EQ35055008-7564BD2D-0996-41CD-8A9B-5F3917BF3318Q35538100-EDFDEDC6-0FD7-49AA-A384-364B71B0AB2BQ35799028-13C039E4-D448-4D65-813B-8FAD387EEA95Q35984951-ADF88B68-8441-46CB-9602-241D46EBFCFFQ36009299-92F6CEBD-49D9-48DE-8A9B-F693530B92DEQ36207699-EB4E1F96-2CFD-43EB-BB1F-392DA78884E3Q36336701-5D5957D1-74B7-49DE-A429-125B05A23ED0Q36467712-40570269-A2E6-4ED3-8A76-BC53F1FC8422Q36476993-FA27D789-670C-414F-A15B-E3861B2641CEQ36546645-BF0F5E50-AF60-4782-8D9B-673B0E2A22FDQ36622333-30FD9BDE-C779-450B-A543-0C8D012C2D57Q36630132-CD987D1A-2DA1-4193-AA43-09C5C5FCE9A8Q36726239-1ACE7FD4-D67A-4DBF-8391-417B5A5FDB54Q36766317-83C84E24-7698-4F7A-AAE5-EB967B0A4191Q36836092-1E95E970-D793-4A69-8FF1-432F46A60231Q36891400-BD27165F-FCDA-4A5E-84CD-2A899B8D87A9Q36997027-7291EE56-5D91-49A5-9835-A894EA6ED31BQ37304122-6EB4605A-1F15-433E-AFFF-CB46EE016C20Q37367504-4183AF7C-A061-4534-8241-06D6F9262918Q37621377-1029F9A9-E6B9-4C24-81A6-FF2247D5D873Q38116790-978FBC64-791B-455D-B267-A0CD68665D9C
P2860
Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Categorizing a prognostic vari ...... aking about cancer treatments.
@ast
Categorizing a prognostic vari ...... aking about cancer treatments.
@en
type
label
Categorizing a prognostic vari ...... aking about cancer treatments.
@ast
Categorizing a prognostic vari ...... aking about cancer treatments.
@en
prefLabel
Categorizing a prognostic vari ...... aking about cancer treatments.
@ast
Categorizing a prognostic vari ...... aking about cancer treatments.
@en
P1476
Categorizing a prognostic vari ...... aking about cancer treatments.
@en
P2093
J R Glassman
M Mazumdar
P304
P356
10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O
P407
P577
2000-01-01T00:00:00Z